Who We Are

 

NeuClone is a clinical-stage biopharmaceutical company with an exclusive focus on the development and commercialisation of high quality biosimilar products.

 

Led by a team of industry veterans, we are focused on creating a deep pipeline of high quality biosimilars at a scale and price that meets demands of global markets. NeuClone is differentiated by this unmatched pipeline, and a trademark Right From the Start® approach – through which we continually confirm biosimilarity at the earliest stages and throughout development.

Ellipse2_background-01

Who We Are

 

NeuClone is a clinical-stage biopharmaceutical company with an exclusive focus on the development and commercialisation of high quality biosimilar products.

 

Led by a team of industry veterans, we are focused on creating a deep pipeline of high quality biosimilars at a scale and price that meets demands of global markets. NeuClone is differentiated by this unmatched pipeline, and a trademark Right From the Start® approach – through which we continually confirm biosimilarity at the earliest stages and throughout development.

 

Our Vision

Increasing affordability and patient access to life saving and life extending therapies.

 

Our Mission

Developing a diverse portfolio of clinically identical biosimilars for patients, globally.

 

Our Values

We value affordable access to healthcare, the quality and integrity of our science, and a strong patient focus.

MORE ON BIOSIMILARS